February 2025 – Volume 166 – Issue 2 : PAIN
PAIN publishes research on the nature, mechanisms and treatment of pain. The journal provides a forum for the dissemination of research in the basic and clinical sciences of multidisciplinary interest.
Related Articles
QoC
Register for free learning The workup and management of patients with Giant Cell Arteritis In this upcoming webinar on vasculitis, Christina Ponte, Christian Dejaco, and…
ACR on Air: The Year Ahead for ACR & ARP
Happy New Year, Dear Listener! We’re back for 2025 and have with us Dr. Carol Langford, President of The American College of Rheumatology (ACR) and…
Bilateral Normal Tension Glaucoma in a Healthy Child… : Journal of Glaucoma
An abstract is unavailable.
An immunosenescent CD8+ T cell subset in patients with axial Spondyloarthritis and Psoriatic Arthritis links spontaneous motility to telomere shortening and dysfunction
Objective A pathogenetic role of CD8+ T lymphocytes in radiographic axial spondyloarthritis (r-axSpA) and other spondyloarthritis (SpA) is sustained by genome-wide association studies (GWAS) and…
N-acetyl-tryptophan in Acute Kidney Injury after Cardiac… : Journal of the American Society of Nephrology
cute kidney injury (AKI) following cardiac surgery were enrolled. High-performance liquid chromatography coupled with mass spectrometry was used for untargeted analysis of metabolites in plasma,…
Why might fears and worries persist after a pain… : PAIN Reports
o participants’ beliefs and feelings that might explain why fears and worries persist after a PE-grounded intervention for CLBP. Methods: We conducted a qualitative study…
Characterizing phenotypes and clinical and health… : PAIN
associations with clinical and sociodemographic factors, health care utilization, and medicine use of young people. Young people ≥15.0 and <25.0 years captured in PaedePPOC and…
Pemivibart only option against ‘false reassurance’ of reduced SARS-CoV-2 virulence
The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal antibody product — but it may not be…
